Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): Implications on imaging of atherosclerotic plaques

Atherosclerosis

Volumn 193, Issue 1, 2007, Pages 102-111

  von zur Muhlen, C ^a   von Elverfeldt, D ^a   Bassler, N ^c   Neudorfer, I ^a   Steitz, B ^b   Petri Fink, A ^b   Hofmann, H ^b   Bode, C ^a   Peter, K ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b EPFL   (Switzerland)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Mac 1; Macrophages; Magnetic resonance imaging; Superparamagnetic iron oxide

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; INTEGRIN RECEPTOR; PROTEIN MAC 1; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROTIC PLAQUE; COMPLEMENT ACTIVATION; DRUG BINDING; DRUG UPTAKE; ENDOCYTOSIS; FLOW CYTOMETRY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LEUKOCYTE ADHERENCE; MACROPHAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PRIORITY JOURNAL;

ANIMALS; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT, ACTIVE; CHO CELLS; CRICETINAE; CRICETULUS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERRIC COMPOUNDS; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGE-1 ANTIGEN; METAL NANOPARTICLES; MONOCYTES; RECOMBINANT PROTEINS;

EID: 34248635938     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.08.048     Document Type: Article

References (31)

1. Schneider J.E., et al. High-resolution, multicontrast three-dimensional-MRI characterizes atherosclerotic plaque composition in apoE-/- mice ex vivo. J Magn Reson Imaging 20 6 (2004) 981-989
2. McAteer M.A., et al. Quantification and 3D reconstruction of atherosclerotic plaque components in apolipoprotein E knockout mice using ex vivo high-resolution MRI. Arterioscler Thromb Vasc Biol 24 12 (2004) 2384-2390
3. Yuan C., and Kerwin W.S. MRI of atherosclerosis. J Magn Reson Imaging 19 6 (2004) 710-719
4. Kooi M.E., et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107 19 (2003) 2453-2458
5. Ruehm S.G., et al. Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103 3 (2001) 415-422
6. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 2 (1999) 115-126
7. Steinberg D., and Witztum J.L. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?. Circulation 105 17 (2002) 2107-2111
8. Langheinrich A.C., and Bohle R.M. Atherosclerosis: humoral and cellular factors of inflammation. Virchows Arch 446 2 (2005) 101-111
9. Litovsky S., et al. Superparamagnetic iron oxide-based method for quantifying recruitment of monocytes to mouse atherosclerotic lesions in vivo: enhancement by tissue necrosis factor-alpha, interleukin-1beta, and interferon-gamma. Circulation 107 11 (2003) 1545-1549
10. Beckmann N., et al. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med 49 3 (2003) 459-467
11. Rausch M., et al. In vivo visualization of phagocytotic cells in rat brains after transient ischemia by USPIO. NMR Biomed 15 4 (2002) 278-283
12. Will O., et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 7 1 (2006) 52-60
13. Raynal I., et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 39 1 (2004) 56-63
14. Rogers W.J., and Basu P. Factors regulating macrophage endocytosis of nanopar ticles: implications for targeted magnetic resonance plaque imaging. Atherosclerosis 178 1 (2005) 67-73
15. Schuler P., et al. Adhesion of monocytes to medical steel as used for vascular stents is mediated by the integrin receptor Mac-1 (CD11b/CD18; alphaM beta2) and can be inhibited by semiconductor coating. Cell Commun Adhes 10 1 (2003) 17-26
16. Kanse S.M., et al. Vitronectin is a ligandfor the β2 integrin Mac-1 (αmβ2 D11b/CD18) and this interaction promotes leukocyte adhesion. Arterioscler Thromb Vasc Biol 24 (2004) 2251-2256
17. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 110 6 (2002) 673-687
18. Jongstra-Bilen J., Harrison R., and Grinstein S. Fcgamma-receptors induce Mac-1 (CD11b/CD18) mobilization and accumulation in the phagocytic cup for optimal phagocytosis. J Biol Chem 278 46 (2003) 45720-45729
19. Taborda C.P., and Casadevall A. CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 16 6 (2002) 791-802
20. Petri-Fink A., et al. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26 15 (2005) 2685-2694
21. Chastellain M., Petri A., and Hofmann H. Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J Colloid Interface Sci 278 2 (2004) 353-360
22. Bourrinet P., et al. Preclinical safety andpharmacokineticprofile offerumoxtran-10, an ultrasmall superparamagnetic iron oxide magnetic resonance contrast agent. Invest Radiol 41 3 (2006) 313-324
23. Peter K., et al. Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation 100 14 (1999) 1533-1539
24. Renkin E.M. Multiple pathways of capillary permeability. Circ Res 41 6 (1977) 735-743
25. Shapiro E.M., Skrtic S., and Koretsky A.P. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn Reson Med 53 2 (2005) 329-338
26. Yancy A.D., et al. Differential uptake offerumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. J Magn Reson Imaging 21 4 (2005) 432-442
27. Gupta A.K., and Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26 13 (2005) 1565-1573
28. Wilhelm C., et al. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 24 6 (2003) 1001-1011
29. Petri-Fink A.C.M., Juillerat-Jeanneret L., Ferrari A., and Hofmann H. Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26 (2005) 1694-2685
30. Stroh A., et al. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic Biol Med 36 8 (2004) 976-984
31. Cengelli F., et al. Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 318 (2006) 108-116